Report ID: SQMIG35H2206
Report ID:
SQMIG35H2206 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
65 |
Figures:
75
North America emerges as the dominant regional segment in the DNA polymerase market. The escalating prevalence of chronic diseases such as cancer, diabetes, and others has led to an increased demand for DNA polymerase in biotechnology laboratories. This polymerase is crucial for DNA replication and subsequent extension, thus driving its market growth. For instance, according to the World Health Organization (WHO), in the United States alone, there are approximately 37.3 million individuals living with diabetes, 96 million adults with prediabetes, and an estimated annual cost of $327 billion associated with diabetes. The market for DNA polymerase is expected to expand further due to the growing adoption of recombinant medications for the treatment of chronic diseases.
Meanwhile, the Asia-Pacific region showcases lucrative growth prospects during the forecast period. This can be attributed to the thriving biotechnology sector, with numerous businesses and academic institutions actively involved in the development and application of DNA polymerase. Factors contributing to this growth include a high prevalence of target disorders, increased funding for genomic research, and a growing awareness of genetic testing in the region.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2206